Cogent Biosciences, Inc.
COGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$256 | -$192 | -$140 | -$72 |
| Dep. & Amort. | $4 | $4 | $6 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $40 | $31 | $18 | $12 |
| Change in WC | $12 | $11 | $1 | $2 |
| Other Non-Cash | -$8 | -$7 | -$3 | -$0 |
| Operating Cash Flow | -$208 | -$154 | -$119 | -$59 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$3 | -$7 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$256 | -$349 | -$178 | $0 |
| Inv. Sales/Matur. | $294 | $254 | $60 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $38 | -$98 | -$125 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $213 | $162 | $162 | $38 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $2 | $2 | -$0 |
| Financing Cash Flow | $214 | $164 | $164 | $38 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $45 | -$88 | -$80 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $141 | $221 | $243 |
| End Cash | $98 | $53 | $141 | $221 |
| Free Cash Flow | -$208 | -$156 | -$126 | -$60 |